ReWalk Robotics plans on selling 3.35 million of its shares in an IPO that will trade on the NASDAQ under the ticker symbol “RWLK.” The pricing terms were not disclosed. Barclays Capital and Jefferies will serve as underwriters. Based in the U.S., Israel and Germany, ReWalk is a maker of wearable robotic exoskeletons for individuals with spinal cord injury. Its backers include SCP Vitalife Partners. Yaskawa Electric Corp. Israel Healthcare Ventures, Pontifax and Previz Ventures.
YOKNEAM ILIT, ISRAEL / MARLBOROUGH, MASSACHUSETTS, August 26, 2014 – ReWalk Robotics Ltd. (“ReWalk”) today announced that it has commenced an initial public offering of 3,350,000 ordinary shares pursuant to a registration statement on Form F-1 filed with the Securities and Exchange Commission. ReWalk has applied to list its ordinary shares on the Nasdaq Global Market under the ticker symbol “RWLK.” The underwriters will be granted a 30-day option to purchase up to 502,500 additional ordinary shares from ReWalk.
Barclays Capital Inc. and Jefferies LLC will act as joint book-running managers for the proposed offering. Canaccord Genuity Inc. will act as co-manager for the proposed offering.
The offering will be made only by means of a prospectus. A copy of the preliminary prospectus relating to the offering may be obtained from either: Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Ave, Edgewood, NY 11717, 888-603-5847, email: Barclaysprospectus@broadridge.com or Jefferies LLC, 520 Madison Ave, 2nd Floor, New York, NY 10022, 877-547-6340, email: Prospectus_Department@Jefferies.com.
A registration statement relating to these securities has been filed with the Securities and Exchange Commission, but has not yet become effective. These securities may not be sold nor may offers to buy these securities be accepted prior to the time the registration statement becomes effective.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About ReWalk Robotics Ltd.
ReWalk Robotics Ltd. (formerly Argo Medical Technologies Ltd.) develops, manufactures and markets wearable robotic exoskeletons for individuals with spinal cord injury. ReWalk’s mission is to fundamentally change the health and life experiences of individuals with spinal cord injury. Founded in 2001, ReWalk has headquarters in the US, Israel and Germany.